Allen Institute for Artificial Intelligence logo

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 months ago

Possible Interaction: Emodin and Recombinant Vascular Endothelial Growth Factor

Research Papers that Mention the Interaction

The antitumor function of emodin , attributed to the Notch signaling pathway, induced the downregulation of VEGF by suppressing tumorigenesis and angiogenesis, which indicated a novel mechanism underlying the emodin-mediated anti-prostate cancer effect.
The mRNA and protein expression of Notch1 … and protein expression levels of Jagged1, VEGF … emodin for 24 h. The LSCM assay revealed that the Notch1 was not only localized in the membrane … the PC3 cells, and the expression of Notch1 in the nuclei gradually increased following treatment with emodin.
Molecular medicine reports  •  2015  |  View Paper
AE suppressed the nuclear translocation and DNA binding of NF-κB, which is an important transcription factor for controlling MMP-2/9 and VEGF gene expression.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences  •  2012  |  View Paper
Also, enzyme …) revealed that emodin significantly reduced the production of pro-inflammatory cytokines [tumor necrosis factor-alpha (TNF-α), IL-…], mediators [prostagladin E(2) (PGE(2)), matrix metalloproteinase (MMP)-1 and MMP-13] and vascular endothelial growth factor (VEGF) as an angiogenesis biomarker in … LPS-treated synoviocytes under hypoxia.
Consistently, emodin attenuated the expression of cyclooxygenase 2 (COX-2), VEGF , hypoxia inducible factor 1 alpha (HIF-1α), MMP-1 and MMP-13 at mRNA level in IL-1β and LPS-treated synoviocytes under hypoxia.
Biological & pharmaceutical bulletin  •  2011  |  View Paper
In our study, we found that emodin inhibited the invasion and migration abilities of RKO cells and decreased the expression of matrix metalloproteinase-7 (MMP-7), MMP-9, and vascular endothelial growth factor (VEGF) in a dose-dependent manner.
Oncology research  •  2019  |  View Paper